Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!

Ticker
DSFIR.AS

Price
97.88
Stock movement down
-0.22 (-0.22%)
Company name
DSM-Firmenich AG
Exchange
(AS
,
Currency
EUR
)
Sector
Basic Materials >
Specialty Chemicals
Markkapitalisasie
25.97B
Ondernemingswaarde
34.71B
Prys/Verkope
2.02
Prys/Boek
1.13
Dividendopbrengs
-
Dividendgroei
-
Groei jare
-
FCF uitbetaling
27.47%
Agterlopende P/E
-
Volgende P/E
32.30
PEG
-
EPS groei
-
1 jaar opbrengs
6.22%
3 jaar opbrengs
-
5 jaar opbrengs
-
10 jaar opbrengs
-
Laaste opgedateer: 2024-12-21

DIVIDENDE

DSFIR.AS betaal nie dividende nie of geen data is ontvang nie

WAARDERING

Waarderingsverhoudings

Loading...
Waarderingsverhoudings gegewens
Agterlopende P/E-
Prys tot OCF18.32
Prys tot FCF45.43
Prys tot EBITDA64.83
EV tot EBITDA86.67

Waardering (Verkope/Boekwaarde)

Loading...
Waardering (Verkope/Boekwaarde) gegewens
Prys tot verkope2.02
Prys tot Boekwaarde1.13
EV tot verkope2.70

FINANSIËLE

Per aandeel

Loading...
Per aandeel gegewens
Huidige aandeeltelling265.28M
EPS (TTM)-3.25
FCF per aandeel (TTM)2.15

Inkomstestaat

Loading...
Inkomstestaat gegewens
Inkomste (TTM)12.86B
Bruto wins (TTM)3.57B
Bedryfsinkomste (TTM)-427.50M
Netto inkomste (TTM)-865.00M
EPS (TTM)-3.25
EPS (1j vorentoe)3.03

Marges

Loading...
Marges gegewens
Bruto marge (TTM)27.76%
Bedryfsmarge (TTM)-3.32%
Winsgrens (TTM)-6.73%

Balansstaat

Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Balansstaat gegewens
Kontant2.46B
Netto debiteure2.55B
Totale bedryfsbates8.84B
Klandisiewaarde11.29B
Ontasbare bates7.45B
Eiendom, aanleg en toerusting0.00
Totale bates34.27B
Rekeninge betaalbaar2.07B
Kort/huidige langtermynskuld4.83B
Totale bedryfslaste4.52B
Totale laste11.20B
Aandeelhouersbelang23.07B
Netto tasbare bates0.00

Kontantvloei

Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Kontantvloei gegewens
Bedryfskontantvloei (TTM)1.42B
Kapitale uitgawes (TTM)846.00M
Vrye kontantvloei (TTM)571.50M
Dividende betaal (TTM)157.00M

Finansiële opbrengste

Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Finansiële opbrengste gegewens
Opbrengs op ekwiteit-3.75%
Opbrengs op bates-2.52%
Opbrengs op belegde kapitaal-3.64%
Kontant opbrengs op belegde kapitaal2.40%

AANDELE INLIGTING

Aandele grafiek

Loading...
Aandele prys data
Open97.92
Daaglikse hoog98.86
Daaglikse laag97.08
Daaglikse volume851K
Hoogtepunt van alle tye123.65
1j analiseraaming132.20
Beta-
EPS (TTM)-3.25
Dividend per aandeel-
Ex-dividend datum9 May 2024
Volgende verdienste datum13 Feb 2025

Afwaartse potensiaal

Loading...
Afwaartse potensiaal gegewens
DSFIR.ASS&P500
Huidige prysdaling vanaf die hoogste punt van alle tye-20.84%-2.74%
Hoogste prysdaling-36.94%-56.47%
Datum van hoogste daling24 Oct 20239 Mar 2009
Gemiddelde daling vanaf hoogtepunt-16.86%-11.13%
Gemiddelde tyd tot nuwe hoogtepunt108 days12 days
Maksimum tyd tot nuwe hoogtepunt346 days1805 days
MAATSKAPPY BESONDERHEDE
DSFIR.AS (DSM-Firmenich AG) company logo
Markkapitalisasie
25.97B
Markkapitalisasie kategorie
Large-cap
Beskrywing
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, cultures, hydrocolloids, proteins, natural colorants, nutritional ingredients, premixes and yeast extracts solutions. The Animal Nutrition & Health segment offers animal proteins, as well as vitamins, performance solutions, and data-driven precision services for the animal production industry. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, biomedical materials, and nutrition improvement markets. This segment offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise services, and customized solutions. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
Werknemers
27926
Beleggerverhoudings
-
CEO
Land
Netherlands
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Loading...
VERSTAAN DIE BESIGHEID
Loading...
MAATSKAPPY NUUS
Alle nuusPersvrystellings
Key Insights DSM-Firmenich's estimated fair value is €115 based on 2 Stage Free Cash Flow to Equity Current share price...
11 November 2024
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.comNEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor confer...
26 September 2024
Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual eventMAASTRICHT, The Netherlands, Sept. 23, 2024 (GLOBE NEWSWIRE) -- dsm-firmenich...
23 September 2024
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Tuesday, September 24 and Wednesday, Septembe...
19 September 2024
Key Insights DSM-Firmenich's significant retail investors ownership suggests that the key decisions are influenced by...
12 Augustus 2024
Key Insights DSM-Firmenich's estimated fair value is €119 based on 2 Stage Free Cash Flow to Equity With €101 share...
4 Junie 2024
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced DSM Firmenich AG ...
4 April 2024
Key Insights Significant control over DSM-Firmenich by retail investors implies that the general public has more power...
4 Maart 2024
Key Insights Using the 2 Stage Free Cash Flow to Equity, DSM-Firmenich fair value estimate is €114 With €91.43 share...
27 Desember 2023